Nctid:
NCT00000107
Payload:
{"hasResults"=>false, "derivedSection"=>{"miscInfoModule"=>{"versionHolder"=>"2024-12-20"}, "conditionBrowseModule"=>{"meshes"=>[{"id"=>"D006330", "term"=>"Heart Defects, Congenital"}, {"id"=>"D000013", "term"=>"Congenital Abnormalities"}], "ancestors"=>[{"id"=>"D006331", "term"=>"Heart Diseases"}, {"id"=>"D002318", "term"=>"Cardiovascular Diseases"}, {"id"=>"D018376", "term"=>"Cardiovascular Abnormalities"}], "browseLeaves"=>[{"id"=>"M9419", "name"=>"Heart Diseases", "relevance"=>"LOW"}, {"id"=>"M9418", "name"=>"Heart Defects, Congenital", "asFound"=>"Heart Defects, Congenital", "relevance"=>"HIGH"}, {"id"=>"M12", "name"=>"Congenital Abnormalities", "asFound"=>"Defects, Congenital", "relevance"=>"HIGH"}, {"id"=>"M20503", "name"=>"Cardiovascular Abnormalities", "relevance"=>"LOW"}], "browseBranches"=>[{"name"=>"Heart and Blood Diseases", "abbrev"=>"BC14"}, {"name"=>"All Conditions", "abbrev"=>"All"}, {"name"=>"Diseases and Abnormalities at or Before Birth", "abbrev"=>"BC16"}]}}, "protocolSection"=>{"designModule"=>{"studyType"=>"OBSERVATIONAL", "designInfo"=>{"observationalModel"=>"CASE_CONTROL"}}, "statusModule"=>{"overallStatus"=>"COMPLETED", "expandedAccessInfo"=>{"hasExpandedAccess"=>false}, "statusVerifiedDate"=>"2003-12", "lastUpdateSubmitDate"=>"2005-06-23", "studyFirstSubmitDate"=>"2000-01-18", "studyFirstSubmitQcDate"=>"2000-01-18", "lastUpdatePostDateStruct"=>{"date"=>"2005-06-24", "type"=>"ESTIMATED"}, "studyFirstPostDateStruct"=>{"date"=>"2000-01-19", "type"=>"ESTIMATED"}}, "conditionsModule"=>{"keywords"=>["Cyanotic Congenital Heart Disease"], "conditions"=>["Heart Defects, Congenital"]}, "descriptionModule"=>{"briefSummary"=>"Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight."}, "eligibilityModule"=>{"sex"=>"ALL", "stdAges"=>["CHILD", "ADULT"], "maximumAge"=>"60 years", "minimumAge"=>"17 years", "healthyVolunteers"=>true, "eligibilityCriteria"=>"Inclusion Criteria:\n\n* Resting blood pressure below 140/90"}, "identificationModule"=>{"nctId"=>"NCT00000107", "briefTitle"=>"Body Water Content in Cyanotic Congenital Heart Disease", "organization"=>{"class"=>"NIH", "fullName"=>"National Center for Research Resources (NCRR)"}, "orgStudyIdInfo"=>{"id"=>"NCRR-M01RR00109-0737"}, "secondaryIdInfos"=>[{"id"=>"M01RR000109", "link"=>"https://reporter.nih.gov/quickSearch/M01RR000109", "type"=>"NIH"}]}, "contactsLocationsModule"=>{"locations"=>[{"zip"=>"05401", "city"=>"Burlington", "state"=>"Vermont", "country"=>"United States", "facility"=>"University of Vermont", "geoPoint"=>{"lat"=>44.47588, "lon"=>-73.21207}}]}, "sponsorCollaboratorsModule"=>{"leadSponsor"=>{"name"=>"National Center for Research Resources (NCRR)", "class"=>"NIH"}}}}
